Related Articles
Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas
Spectrum of p53 mutations in biopsies from breast cancer patients selected for preoperative chemotherapy analysed by the functional yeast assay to predict therapeutic response
MUTATION AND EXPRESSION OF THE P53 TUMOR SUPPRESSOR GENE IN TUMOR SAMPLES AND CANCER CELL-LINES - COMPARISON OF NONISOTOPIC DIRECT DNA-SEQUENCING, IMMUNOBLOTTING AND IMMUNOHISTOCHEMISTRY
Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer
Triple‑negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia